People with thyroid eye disease receiving infusions of the insulin-like growth factor-1 receptor veligrotug report improved quality of life after 15 weeks of treatment.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/study-igf-1r-veligrotug-leads-improved-quality-life-thyroid-2025a1000ssj?src=rss
Author :
Publish date : 2025-10-23 05:59:00
Copyright for syndicated content belongs to the linked Source.
